Cardiovascular Research Group, Szeged, Hungary
kislogo Cardiovascular Research Group

Publications of the Cardiovascular Research Group

(cardiovasc™ is a trademark of PharmaHungary)


All Publications 

129.Schreckenberg R, Weber P, Cabrera-Fuentes HA, Steinert I, Preissner KT, Bencsik P, Sárközy M, Csonka C, Ferdinandy P, Schulz R, Schlüter KD. Mechanism and consequences of the shift in cardiac arginine metabolism following ischaemia and reperfusion in rats.
Thromb Haemost. 2014 Dec 11;113(3).

128.Madonna R, Engel FB, Davidson SM, Ferdinandy P, Görbe A, Sluijter JP, Van Laake LW. Stem cell aging and age-related cardiovascular disease: Perspectives of treatment by ex-vivo stem cell rejuvenation.
Curr Drug Targets. 2014 Dec.

127.Sárközy M, Fekete V, Szűcs G, Török S, Szűcs C, Bárkányi J, Varga ZV, Földesi I, Csonka C, Kónya C, Csont T, Ferdinandy P. Anti-diabetic effect of a preparation of vitamins, minerals and trace elements in diabetic rats: a gender difference.
BMC Endocr Disord. 2014 Aug 26;14:72. doi: 10.1186/1472-6823-14-72.

126.Csonka C, Páli T, Bencsik P, Görbe A, Ferdinandy P, Csont T. Measurement of NO in biological samples.
Br J Pharmacol. 2014 Jul 2. doi: 10.1111/bph.12832.

125. Varga ZV, Zvara A, Faragó N, Kocsis GF, Pipicz M, Gáspár R, Bencsik P, Görbe A, Csonka C, Puskás LG, Thum T, Csont T, Ferdinandy P. MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs.
Am J Physiol Heart Circ Physiol. 2014 Jul 15;307(2):H216-27.

124. Csonka C, Szucs G, Varga-Orvos Z, Bencsik P, Csont T, Zvara A, Puskás LG, Ferdinandy P. Ischemic postconditioning alters the gene expression pattern of the ischemic heart.
Exp Biol Med (Maywood). 2014; 239(2):141-50.

123. Bencsik P, Pálóczi J, Kocsis GF, Pipis J, Belecz I, Varga ZV, Csonka C, Görbe A, Csont T, Ferdinandy P. Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective.
Pharmacol Res. 2014; 80:36-42.

122. Kadomatsu K, Bencsik P, Görbe A, Csonka C, Sakamoto K, Kishida S, Ferdinandy P. Therapeutic potential of midkine in cardiovascular disease.
Br J Pharmacol. 2014; 171(4):936-44.

121. Csonka C, Kupai K, Bencsik P, Görbe A, Pálóczi J, Zvara A, Puskás LG, Csont T, Ferdinandy P. Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K+ channel activators cromakalim and diazoxide.
Am J Physiol Heart Circ Physiol. 2014; 306(3):H405-13.

120. Görbe A, Varga ZV, Pálóczi J, Rungarunlert S, Klincumhom N, Pirity MK, Madonna R, Eschenhagen T, Dinnyés A, Csont T, Ferdinandy P. Cytoprotection by the NO-Donor SNAP Against Ischemia/Reoxygenation Injury in Mouse Embryonic Stem Cell-Derived Cardiomyocytes.
Mol Biotechnol. 2013; In Press.

119. Csont T, Sárközy M, Szűcs G, Szűcs C, Bárkányi J, Bencsik P, Gáspár R, Földesi I, Csonka C, Kónya C, Ferdinandy P. Effect of a multivitamin preparation supplemented with phytosterol on serum lipids and infarct size in rats fed with normal and high cholesterol diet.
Lipids Health Dis. 2013; 12:138.

118. Varga ZV, Kupai K, Szűcs G, Gáspár R, Pálóczi J, Faragó N, Zvara A, Puskás LG, Rázga Z, Tiszlavicz L, Bencsik P, Görbe A, Csonka C, Ferdinandy P, Csont T. MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart.
J Mol Cell Cardiol. 2013; 62:111-21.

117. Szűcs G, Murlasits Z, Török S, Kocsis GF, Pálóczi J, Görbe A, Csont T, Csonka C, Ferdinandy P. Cardioprotection by farnesol: role of the mevalonate pathway.
Cardiovasc Drugs Ther. 2013; 27(4):269-77.

116. Fekete V, Murlasits Z, Aypar E, Bencsik P, Sárközy M, Szénási G, Ferdinandy P, Csont T. Myocardial postconditioning is lost in vascular nitrate tolerance.
J Cardiovasc Pharmacol. 2013; 62(3):298-303.

115. Madonna R, Görbe A, Ferdinandy P, De Caterina R. Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells.
Mol Biotechnol. 2013; 55(2):169-78.

114. Lecour S, Ferdinandy P, Eisner D. May 2013 sees the celebration of the 80th Birthday of Lionel Opie, founder of the Journal of Molecular and Cellular Cardiology.
J Mol Cell Cardiol. 2013; 58:1-2.

113. Sárközy M, Zvara A, Gyémánt N, Fekete V, Kocsis GF, Pipis J, Szűcs G, Csonka C, Puskás LG, Ferdinandy P, Csont T. Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats.
Cardiovasc Diabetol. 2013; 12:16.

112. Monostori P, Kocsis GF, Ökrös Z, Bencsik P, Czétényi O, Kiss Z, Gellén B, Bereczki C, Ocsovszki I, Pipis J, Pálóczi J, Sárközy M, Török S, Varga IS, Kiss I, Fodor E, Csont T, Ferdinandy P, Túri S. Different administration schedules of darbepoetin alfa affect oxidized and reduced glutathione levels to a similar extent in 5/6 nephrectomized rats.
Clin Exp Nephrol. 2013; 17(4):569-74.

111. Schulz R, Ferdinandy P. Does nitric oxide signaling differ in pre- and post-conditioning? Importance of S-nitrosylation vs. protein kinase G activation.
Free Radic Biol Med. 2013; 54:113-5.

110. Csont T, Ferdinandy P. Letter by Csont and Ferdinandy regarding article, "ischemic conditioning protects the uremic heart in a rodent model of myocardial infarction".
Circulation. 2012; 126(13):e212.

109. Kocsis GF, Sárközy M, Bencsik P, Pipicz M, Varga ZV, Pálóczi J, Csonka C, Ferdinandy P, Csont T. Preconditioning protects the heart in a prolonged uremic condition.
Am J Physiol Heart Circ Physiol. 2012; 303(10):H1229-36.

108. Faragó N, Zvara A, Varga Z, Ferdinandy P, Puskás LG. Purification of high-quality micro RNA from the heart tissue.
Acta Biol Hung. 2011; 62(4):413-25.

107. Szucs G, Bester DJ, Kupai K, Csont T, Csonka C, Esterhuyse AJ, Ferdinandy P, Van Rooyen J. Dietary red palm oil supplementation decreases infarct size in cholesterol fed rats.
Lipids Health Dis. 2011; 10:103.

106. Görbe A, Varga ZV, Kupai K, Bencsik P, Kocsis GF, Csont T, Boengler K, Schulz R, Ferdinandy P. Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43.
Am J Physiol Heart Circ Physiol. 2011; 300(5):H1907-13.

105. Bester DJ, Kupai K, Csont T, Szucs G, Csonka C, Esterhuyse AJ, Ferdinandy P, Van Rooyen J. Dietary red palm oil supplementation reduces myocardial infarct size in an isolated perfused rat heart model.
Lipids Health Dis. 2010; 9:64.

104. Bencsik P, Kupai K, Giricz Z, Görbe A, Pipis J, Murlasits Z, Kocsis GF, Varga-Orvos Z, Puskás LG, Csonka C, Csont T, Ferdinandy P. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
Am J Physiol Heart Circ Physiol. 2010; 299(2):H512-8.

103. Dormán G, Cseh S, Hajdú I, Barna L, Kónya D, Kupai K, Kovács L, Ferdinandy P. Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.
Drugs. 2010; 70(8):949-64.

102. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R; Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Working Group of Cellular Biology of Heart of European Society of Cardiology.
Cardiovasc Res. 2010; 87(3):406-23.

101. Gorbe A, Giricz Z, Szunyog A, Csont T, Burley DS, Baxter GF, Ferdinandy P. Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation.
Basic Res Cardiol. 2010; 105(5):643-50.

100. Csonka C, Kupai K, Kocsis GF, Novák G, Fekete V, Bencsik P, Csont T, Ferdinandy P. Measurement of myocardial infarct size in preclinical studies.
J Pharmacol Toxicol Methods. 2010; 61(2):163-70.

99. Kupai K, Szucs G, Cseh S, Hajdu I, Csonka C, Csont T, Ferdinandy P. Matrix metalloproteinase activity assays: Importance of zymography.
J Pharmacol Toxicol Methods. 2010; 61(2):205-9.

98. Csont T, Görbe A, Bereczki E, Szunyog A, Aypar E, Tóth ME, Varga ZV, Csonka C, Fülöp F, Sántha M, Ferdinandy P. Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: role of nitric oxide.
J Mol Cell Cardiol. 2010; 48(4):649-52.

97. Kocsis GF, Csont T, Varga-Orvos Z, Puskas LG, Murlasits Z, Ferdinandy P. Expression of genes related to oxidative/nitrosative stress in mouse hearts: effect of preconditioning and cholesterol diet.
Med Sci Monit. 2010; 16(1):BR32-9.

96. Posa A, Pavo N, Hemetsberger R, Csonka C, Csont T, Ferdinandy P, Petrási Z, Varga C, Pavo IJ, Laszlo F Jr, Huber K, Gyöngyösi M. Protective effect of ischaemic preconditioning on ischaemia/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs.
Thromb Haemost. 2010; 103(2):450-60.

95. Giricz Z, Görbe A, Pipis J, Burley DS, Ferdinandy P, Baxter GF. Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3',5'-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats.
Br J Pharmacol. 2009; 158(6):1495-502.

94. Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, Marais de W, Csont T, Ferdinandy P. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite.
Am J Physiol Heart Circ Physiol. 2009; 297(5):H1729-35.

93. Engelbrecht AM, Odendaal L, Du Toit EF, Kupai K, Csont T, Ferdinandy P, van Rooyen J. The effect of dietary red palm oil on the functional recovery of the ischaemic/reperfused isolated rat heart: the involvement of the PI3-kinase signaling pathway.
Lipids Health Dis. 2009; 8:18.

92. Süle Z, Mracskó E, Bereczki E, Sántha M, Csont T, Ferdinandy P, Bari F, Farkas E. Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice.
Life Sci. 2009; 84(25-26):935-9.

91. Sallo FB, Bereczki E, Csont T, Luthert PJ, Munro P, Ferdinandy P, Sántha M, Lengyel I. Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes.
Exp Eye Res. 2009; 89(2):178-86.

90. Lakkisto P, Csonka C, Fodor G, Bencsik P, Voipio-Pulkki LM, Ferdinandy P, Pulkki K. The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43.
Scand J Clin Lab Invest. 2009; 69(2):209-18.

89. Csont T, Ferdinandy P. Letter by Csont and Ferdinandy regarding article, "Biglycan is required for adaptive remodeling after myocardial infarction".
Circulation. 2008; 118(15):e52

88. Bereczki E, Bernát G, Csont T, Ferdinandy P, Scheich H, Sántha M.
Overexpression of human apolipoprotein B-100 induces severe neurodegeneration in transgenic mice.
J Proteome Res. 2008; 7(6):2246-52.

87. Kocsis GF, Pipis J, Fekete V, Kovacs-Simon A, Odendaal L, Molnar E, Giricz Z, Janaky T, van Rooyen J, Csont T, Ferdinandy P.
Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.
Am J Physiol Heart Circ Physiol. 2008
; 294(5):H2406-H2409.

86. Faragó N, Kocsis GF, Fehér LZ, Csont T, Hackler L Jr, Varga-Orvos Z, Csonka C, Kelemen JZ, Ferdinandy P, Puskás LG.
Gene and protein expression changes in response to normoxic perfusion in mouse
hearts.
J Pharmacol Toxicol Methods. 2008; 57(2):145-54.

85. Dormán G, Kocsis-Szommer K, Spadoni C, Ferdinandy P.
MMP inhibitors in cardiac diseases: an update.
Recent Patents Cardiovasc Drug Discov. 2007; 2(3):186-94.

84. Ferdinandy P, Schulz R, Baxter GF.
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Pharmacol Rev. 2007; 59(4):418-58.

83. Bencsik P, Kupai K, Giricz Z, Görbe A, Huliák I, Fürst S, Dux L, Csont T,Jancsó G, Ferdinandy P.
Cardiac capsaicin-sensitive sensory nerves regulate myocardial relaxation via S-nitrosylation of SERCA: role of peroxynitrite.
Br J Pharmacol. 2008; 153(3):488-96.

82. Stef G, Csiszar A, Ziangmin Z, Ferdinandy P, Ungvari Z, Veress G.
Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance.
Pharmacol Rep. 2007; 59(4):428-36.

81. Burley DS, Ferdinandy P, Baxter GF.
Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.
Br J Pharmacol. 2007
; 152(6):855-69.

80. Csont T, Bereczki E, Bencsik P, Fodor G, Görbe A, Zvara A, Csonka C, Puskás LG, Sántha M, Ferdinandy P.
Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice.
Cardiovasc Res. 2007; 76(1):100-9.

79. Bereczki E, Gonda S, Csont T, Korpos E, Zvara A, Ferdinandy P, Santha M.   
Overexpression of biglycan in the heart of transgenic mice: an antibody microarray study.
J Proteome Res. 2007; 6(2):854-61.

78. Orosz Z, Csiszar A, Labinskyy N, Smith K, Kaminski PM, Ferdinandy P, Wolin MS, Rivera A, Ungvari Z.
Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation.
Am J Physiol Heart Circ Physiol  2007; 292:H130-139
.


77. Balogh E, Czuriga I, Bereczky Z, Boda K, Koszegi Z, Konya C, Csaszar A, Muszbek L, Edes I, Ferdinandy P.  
[Increase of homocysteine in cardiovascular diseases in Hungary]
Orv Hetil 2006; 147:1685-1690
.

76. Gyongyosi M, Strehblow C, Sperker W, Hevesi A, Garamvolgyi R, Petrasi Z, Pavo N, Ferdinandy P, Csonka C, Csont T, Sylven C, Declerck PJ, Pavo I Jr, Wojta J, Glogar D, Huber K. 
Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours.
Thromb Haemost 200
6; 96:202-209.

75. Bjelik A, Bereczki E, Gonda S, Juhasz A, Rimanoczy A, Zana M, Csont T, Pakaski M, Boda K, Ferdinandy P, Dux L, Janka Z, Santha M, Kalman J.   
Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis.
Neurochem Int 200
6; 49:393-400.

74. Ferdinandy P.   
Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well?
Br J Pharmacol 2006; 148:1-3
.

73. Turan N, Csonka C, Csont T, Giricz Z, Fodor G, Bencsik P, Gyongyosi M, Cakici I, Ferdinandy P.
The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts.
Cardiovasc Res  2006; 70:384-390
.

72. Kónya C, Ferdinandy P.
Vitamin C: new role of the old vitamin in the cardiovascular system?
Br J Pharmacol 2006; 147:125-127.

71. Giricz Z, Lalu MM, Csonka C, Bencsik P, Schulz R, Ferdinandy P.
Hyperlipidemia attenuates the infarct-size limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.
J Pharmacol Exp Ther  200
6; 316:154-61.

70. Sőti C,  Nagy E,  Giricz Z, Vígh L, Csermely P, Ferdinandy P.
Heat shock proteins as emerging therapeutic targets.
Br J Pharmacol 
2005; 146:769-80.

69. Zvara A, Bencsik P, Fodor G, Csont T, Hackler Jr L, Dux M, Fürst S, Jancsó G, Puskás LG, Ferdinandy P. Capsaicin-sensitive sensory neurons regulate myocardial function and gene expression pattern of rat hearts: a DNA microarray study.
FASEB J
2006; 20:160-162.

68.
Ungi I, Ungi T, Ruzsa Z, Nagy E, Zimmermann Z, Csont T, Ferdinandy P.
Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty.
Chest 2005; 128:1623-1628
.

67. Csont T, Ferdinandy P.
Direct myocardial protective effect of glyceryl trinitrate: beyond vascular nitrate tolerance.
Pharmacol Therapeut
2005; 105:57-68.

66. Puskas LG, Bereczki E, Santha M, Vigh L, Csanadi G, Spener F, Ferdinandy P, Onody A, Kitajka K.
Cholesterol and cholesterol plus DHA diet-induced gene expression and fatty acid changes in mouse eye and brain.
Biochimie 2004
; 86:817-24.

65. Katona M, Boros M, Santha P, Ferdinandy P, Jancso G.
Selective sensory denervation by capsaicin aggravates adriamycin-induced cardiomyopathy in rats.
Naunyn-Schmiedeberg's Arch Pharmacol  2004; 370:436-443.

64. Puskás LG, Nagy ZB, Giricz Z, Ónody A, Csonka C, Kitajka K, Hackler Jr L, Zvara A, Ferdinandy P.
Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study.
FEBS Lett
 
2004; 562:99-104.

63. Csont T, Csonka C, Kovacs P, Jancso G, Ferdinandy P.
Capsaicin-sensitive sensory neurons regulate myocardial nitric oxide and cGMP signaling.
E
ur J Phramacol 2003; 476:107-13.

62. Giricz Z, Csonka C, Ónody A, Csont T, Ferdinandy P.
Role of cholesterol-enriched diet and the mevalonate pathway in cardiac nitric oxide synthesis.
Basic Res Cardiol
2003; 98:304-10.
   
61. Radak Z, Ogonovszky H, Dubecz J, Pavlik G, Sasvari M, Pucsok J, Berkes I, Csont T, Ferdinandy P.
Super-marathon race increases serum and urinary nitrotyrosine and carbonyl levels.
Eur J Clin Invest
2003; 33:726-30.

60. Csonka C, Ónody A, Csont T, Ferdinandy P.
The defibrillatory action of glibenclamide is independent from ATP-sensitive K+-chanels and free radicals.
J Cardiovasc Pharmacol
2003; 41:916-922.

59. Ónody A, Csonka C, Giricz Z, Ferdinandy P.
Hyperlipidemia induced by cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts.
Cardiovasc Res
2003; 58:663-670.

58.
D'Souza SP, Yellon DM, Martin C, Schulz R, Heusch G, Onody A,  Ferdinandy P, Baxter GF.

Type-B natriuretic peptide (BNP) limits infarct size in rat isolated heart via KATP channel opening.
Am J Physiol Heart Circ Physiol
2003; 284:H1592-600.

57. Ónody A, Zvara A, Hackler L Jr., Vígh L, Ferdinandy P, Puskás LG.
Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study.
FEBS Lett 2003; 536: 35-40.

56. Gao C, Sawicki G,  Suarez-Pinzon WL, Csont T, Wozniak M, Ferdinandy P, Schulz R.
Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction.
Cardiovasc Res 2003; 57:426-33.

55. Ferdinandy P, Schulz R.
Nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury and preconditioning.
Br J Pharmacol 2003; 138: 532-543.

54. Ferdinandy P.
Myocardial ischemia/reperfusion injury and preconditioning: effects of hypercholesterolemia/hyperlipidemia.
Br J Pharmacol 2003; 138: 283-285.

53. Gyongyosi M, Sperker W, Csonka Cs, Bonderman D, Lang I, Strehblow C, Adalbrecht C, Shirazi M, Windberger U, Marlovits S, Gottsauner-Wolff M, Wexberg P, Kockx M, Ferdinandy P, Glogar D.
Inhibition of interleukin-1beta convertase is associated with decrease of neointimal hyperplasia after coronary artery stenting in pigs.
Mol Cell Biochem 2003; 249:39-43.

52. Lalu MM, Csonka C, Giricz Z, Csont T, Schulz R, Ferdinandy P.
Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2.
Biochem Biophys Res Commun 2002; 296:937.

51. Khadour FH, Panas D, Ferdinandy P, Schulze C, Csont T, Lalu MM, Wildhirt SM, Schulz R.
Enhanced NO and superoxide generation in dysfunctional hearts from endotoxemic rats.
Am J Physiol Heart Circ Physiol 2002; 283:H1108-15.

50. Csont T, Csonka C, Ónody A, Görbe A, Dux L, Schulz R. Baxter GF, Ferdinandy P.
Nitrate tolerance does not increase production of peroxynitrite in the heart.
Am J Physiol Heart Circ Physiol 2002; 283:H69-H76.

49. Csont T, Balogh G, Csonka C, Boros I, Horvath I, Vigh L, Ferdinandy P.
Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts.
Biochem Biophys Res Commun 2002; 290:1535-1538.

48. Sari R, Nemeth J, Porszasz R, Horvath P, Blasig IE, Ferdinandy P, Nagy I, Lonovics J, Szilvassy Z.
Impairment by lovastatin of neural relaxation of the rabbit sphincter of Oddi.
Eur J Pharmacol 2002; 432:91-7.

47. Baxter GF, Ferdinandy P.
Delayed preconditioning of myocardium: current perspectives.
Basic Res Cardiol 2001; 96:329-44.

46. Csonka C, Csont T, Onody A, Ferdinandy P.
Preconditioning decreases ischemia/reperfusion-induced peroxynitrite formation.
Biochem Biophys Res Commun 2001; 285:1217-9.

45. Jednakovits A, Ferdinandy P, Jaszlits L, Banyasz T, Magyar J, Szigligeti P, Kortvely A, Szentmiklosi JA, Nanasi PP.
In vivo and in vitro acute cardiovascular effects of bimoclomol.
Gen Pharmacol. 2000; 34:363-9.

44. Pongo E, Balla Z, Mubagwa K, Flameng W, Edes I, Szilvassy Z, Ferdinandy P.
Deterioration of the protein kinase C-K(ATP) channel pathway in regulation of coronary flow in hypercholesterolaemic rabbits.
Eur J Pharmacol 2001; 418:217-23.

43. Pataki T, Bak I, Csonka C, Kovacs P, Varga E, Blasig IE, Tosaki A.
Regulation of ventricular fibrillation by heme oxygenase in ischemic/reperfused hearts.
Antioxid Redox Signal 2001; 3:125-34.

42. Ferdinandy P, Schulz R.
Peroxynitrite: toxic or protective in the heart?
Circ Res 2001; 88:E12-E13.

41. Szilvássy Z, Csont T, Droy-Lefaix MT, Ferdinandy P.
Nitric oxide, peroxynitrite, and cGMP in atherosclerosis-induced hypertensive rabbits: beneficial effects of cicletanine.
J Vasc Res 2001; 38:39-46.

40. Ferdinandy P, Schulz R.
Inhibition of peroxynitrite-induced dityrosine formation with oxidized and reduced thiols, NO donors, and purine-derivatives.
Antiox Redox Signal 2001; 3:165-171.

39. Csonka C, Pataki T, Kovacs P, Muller SL, Schroeter ML, Tosaki A, Blasig IE.
Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts.
Free Rad Biol Med 2000; 29:612-619.

38. Ferdinandy P, Daniel H, Ambrus I, Rothery RA, Schulz R.
Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure in rat hearts.
Circ Res 2000; 87:241-247.

37. Kovacs P, Szilvassy Z, Hegyi P, Nemeth J, Ferdinandy P, Tosaki A.
Effect of transdermal nitroglycerin on glucose-stimulated insulin release in healthy male volunteers.
Eur J Clin Invest 2000; 30:41-44.

36. Csont T, Szilvássy Z, Fülöp F, Nedeianu S, Páli T, Tosaki A, Dux L, Ferdinandy P.
Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cGMP-independent activation of KATP.
Br J Pharmacol 1999; 128:1427-1434.

35. Haines DD, Bak I, Ferdinandy P, Mahmoud FF, Al-Harbi SA, Blasig IE, Tosaki A.
Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts.
J Cardiovasc Pharmacol 2000; 35:37-44.

34. Varga E, Bodi A, Ferdinandy P, Droy-Lefaix MT, Blasig IE, Tosaki A
The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production.
J Cardiovasc Pharmacol 1999; 34:711-7.

33. Csonka C, Szilvassy Z, Fulop F, Pali T, Blasig IE, Tosaki A, Schulz R, Ferdinandy P.
Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts.
Circulation 1999; 100:2260-2266.

32. Csonka C, Varga E, Kovacs P, Ferdinandy P, Blasig IE, Szilvassy Z, Tosaki A
Heme oxygenase and cardiac function in ischemic/reperfused rat hearts.
Free Rad Biol Med 1999; 27:119-26.

31. Ferdinandy P, Panas P, Schulz R.
Peroxynitrite contributes to spontaneous loss of cardiac efficency in isolated working rat hearts.
Am J Physiol 1999; 276:H1861-1867.

30. Oroszi G, Szilvassy Z, Nemeth J, Ferdinandy P, Szolcsanyi J, Tosaki A
Interaction between capsaicin and nitrate tolerance in isolated guinea-pig heart.
Eur J Pharmacol 1999; 368(2-3):R1-3.

29. Ferdinandy P, Szilvassy Z, Csont T, Koltai M, Droy-lefaix MT.
Cardioprotective effect of enantiomers of cicletanine (BN50417, BN50418) in ischaemic/reperfused isolated working rat hearts: interaction with glibenclamide.
Pharmacol Res 1999; 39(3):225-231.

28. Radak Z, Pucsok J, Mecseki S, Csont T, Ferdinandy P.
Muscle soreness-induced reduction in force generation is accompanied by increased nitric oxide content and DNA damage in human skeletal muscle.
Free Rad Biol Med 1999; 26:1059-63.

27. van Beek JH, Csont T, de Kanter FJ, Bussemaker J.
Simple model analysis of 13C NMR spectra to measure oxygen consumption using frozen tissue samples.
Adv Exp Med Biol. 1998; 454:475-85.

26. Szilvassy J, Jancso G, Ferdinandy P
Mechanism of vasodilatation by cochlear nerve stimulation. Role of calcitonin gene-related peptide.
Pharmacol Res 1999; 39(3):217-220.

25. Csont T, Pali T, Szilvassy Z, Ferdinandy P.
Lack of correlation between myocardial nitric oxide and cyclic guanosine monophosphate content in both nitrate-tolerant and -nontolerant rats.
Biochem Pharmacol 1998; 56(9):1139-44.

24. Ferdinandy P, Csonka C, Csont T, Szilvassy Z, Dux L.
Rapid pacing-induced preconditioning is recaptured by farnesol treatment in hearts of cholesterol-fed rats: role of polyprenyl derivatives and nitric oxide.
Mol Cell Biochem 1998; 186(1-2):27-34.

23. Szilvassy Z, Ferdinandy P, Cluff CW, Elliott GT.
Antiischemic effect of monophosphoryl lipid A in conscious rabbits with hypercholesterolemia and atherosclerosis.
J Cardiovasc Pharmacol 1998; 32(2):206-12
.

22. Ferdinandy P, Appelbaum Y, Csonka C, Blasig IE, Tosaki A.
Role of nitric oxide and TPEN, a potent metal chelator, in ischaemic and reperfused rat isolated hearts.
Clin Exp Pharmacol Physiol 1998; 25(7-8):496-502.

21. Ferdinandy P, Szilvassy Z, Baxter GF.
Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon?
Trends Pharmacol Sci 1998; 19:223-9.

20. Ferdinandy P, Fazekas T, Kadar E.
Effect of orotic acidon ischemic/reperfused myocardial function and glycogen content in isolated working rat hearts.
Pharmacol Res 1998; 37:111-114.

19. Ferdinandy P, Szilvassy Z, Horvath LI, Csont T, Csonka C, Nagy E, Szentgyorgyi R, Nagy I, Koltai M, Dux L.
Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet.
J Mol Cell Cardiol 1997; 29:3321-33
.

18. Vigh L, Literati PN, Horvath I, Torok Z, Balogh G, Glatz A, Kovacs E, Boros I, Ferdinandy P, Farkas B, Jaszlits L, Jednakovits A, Koranyi L, Maresca B.
Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects.
Nat Med 1997; 3:1150-4.

17. Ferdinandy P, Csont T, Csonka C, Torok M, Dux M, Nemeth J, Horvath LI, Dux L, Szilvassy Z, Jancso G.
Capsaicin-sensitive local sensory innervation is involved in pacing-induced preconditioning in rat hearts: role of nitric oxide and CGRP?
Naunyn Schmiedebergs Arch Pharmacol 1997; 356(3):356-63.

16. Szekeres L, Szilvassy Z, Ferdinandy P, Nagy I, Karcsu S, Csati S.
Delayed cardiac protection against harmful consequences of stress can be induced in experimental atherosclerosis in rabbits.
J Mol Cell Cardiol 1997; 29(7):1977-83.

15. Szilvassy Z, Ferdinandy P, Nagy I, Jakab I, Koltai M.
The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits.
Br J Pharmacol 1997; 121(3):491-6
.

14. Szilvassy J, Ferdinandy P, Kiss JG, Jori J, Muller J, Czigner J.
Involvement of glibenclamide-sensitive potassium channels in vasorelaxation by cochlear nerve stimulation.
Eur Arch Otorhinolaryngol Suppl 1997; 1:S6-8.

13. Ferdinandy P, Szilvassy Z, Balogh N, Csonka C, Csont T, Koltai M, Dux L
Nitric oxide is involved in active preconditioning in isolated working rat hearts.
Ann N Y Acad Sci 1996; 793:489-93.

12. Szilvassy Z, Ferdinandy P, Szilvassy J, Nagy I, Karcsu S, Lonovics J, Dux L, Koltai M
The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia.
J Mol Cell Cardiol 1995; 27(12):2559-69
.

11. Ferdinandy P, Szilvassy Z, Droy-Lefaix MT, Tarrade T, Koltai M
KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Cardiovasc Res 1995; 30(5):781-7
.

10. Ferdinandy P, Szilvassy Z, Csont T, Csonka C, Nagy E, Koltai M, Dux L
Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin.
Br J Pharmacol 1995; 115(7):1129-31.

9. Ferdinandy P, Szilvassy Z, Koltai M, Dux L
Ventricular overdrive pacing-induced preconditioning and no-flow ischemia-induced preconditioning in isolated working rat hearts.
J Cardiovasc Pharmacol 1995; 25(1):97-104.

8. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Szilvassy J, Nagy I, Lonovics J, Koltai M
Loss of preconditioning in rabbits with vascular tolerance to nitroglycerin.
Br J Pharmacol 1994; 112(4):999-1001.

7. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M
Ventricular overdrive pacing-induced anti-ischemic effect: a conscious rabbit model of preconditioning.
Am J Physiol 1994; 266(5 Pt 2):H2033-41.

6. Szilvassy Z, Koltai M, Ferdinandy P, Jakab I, Lonovics J, Tarrade T, Allard M, Braquet PG
Cromakalim and cicletanine against pacing-induced myocardial ischemia in conscious rabbits.
Life Sci 1994; 54(9):PL125-30
.

5. Ferdinandy P, Szilvassy Z, Koltai M, Tarrade T, Allard M, Braquet P.
Cardiac failure in isolated working rat heart: Effect of cicletanine.
Cardiol Elderly 1994; 2(1):35-44.

4. Ferdinandy P, Das DK, Tosaki A
Pacing-induced ventricular fibrillation leading to oxygen free radical formation in aerobically perfused rat hearts.
J Mol Cell Cardiol 1993; 25(6):683-92.

3. Szilvassy Z, Jakab I, Ferdinandy P, Koltai M, Lonovics J, Tarrade T, Braquet PG
Zaprinast, cicletanine, and verapamil attenuate overdrive pacing-induced myocardial ischemia in conscious rabbits.
Life Sci 1993; 53(1):PL13-8
.

2. Bouma P, Ferdinandy P, Sipkema P, Allaart CP, Westerhof N
Nitric oxide is an important determinant of coronary flow in the isolated blood perfused rat heart.
Basic Res Cardiol 1992; 87(6):570-84
.

1. Ferdinandy P, Koltai M, Tosaki A, Berthet P, Tarrade T, Esanu A, Braquet P
Cicletanine improves myocardial function deteriorated by ischemia/reperfusion in isolated working rat hearts.
J Cardiovasc Pharmacol 1992; 19(2):181-9.